Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer

Vaccination strategies in patients with renal cell carcinoma

Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses

Vaccine therapy in patients with renal cell carcinoma

Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma

Delivery of whole tumor lysate into dendritic cells for cancer vaccination

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma